Association between the cardiometabolic index and chronic kidney disease: a cross-sectional study

Qian Guo1, Yani Wang1, Yuchen Liu1

  • 1Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, China.

PubMed

Insights

Higher cardiometabolic index (CMI), an indicator of central obesity, is linked to increased chronic kidney disease (CKD) risk in the general American population. This study found a significant association between elevated CMI levels and a greater likelihood of developing CKD.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Central obesity is a known risk factor for chronic kidney disease (CKD).
  • The specific relationship between the cardiometabolic index (CMI) and CKD prevalence requires further investigation.
  • Understanding this association is crucial for public health strategies targeting metabolic syndrome and kidney health.

Purpose of the Study:

  • To investigate the correlation between the cardiometabolic index (CMI) and the risk of chronic kidney disease (CKD).
  • To assess the association in a large, representative sample of the general American population.
  • To determine if higher CMI levels are independently associated with increased CKD risk.

Main Methods:

  • A cross-sectional study utilizing data from 64,313 participants aged 20 years and older from the National Health and Nutrition Examination Survey (NHANES) (1999-2020).
  • Participants were categorized into three groups based on CMI tertiles (T1, T2, T3).
  • Logistic regression analysis, incorporating NHANES-recommended weights, was employed to evaluate the association between CMI and CKD.

Main Results:

  • The overall prevalence of CKD among the 21,765 included participants was 12.2%.
  • CKD prevalence increased significantly with rising CMI tertiles, from 8.9% in T1 to 16.0% in T3 (P < 0.001).
  • After adjusting for confounders, higher CMI tertiles demonstrated a significantly higher risk of CKD (T3 vs. T1: OR 1.22, 95% CI 1.05-1.43, P=0.013).

Conclusions:

  • Elevated cardiometabolic index (CMI) is independently associated with an increased risk of chronic kidney disease (CKD).
  • These findings highlight the importance of monitoring CMI as a potential indicator for CKD risk in the general population.
  • Public health initiatives may benefit from incorporating CMI assessment in strategies for preventing and managing kidney disease.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
98
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
95
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Internal Anatomy of the Kidney01:12

Internal Anatomy of the Kidney

The kidneys are essential organs in the human body, performing a myriad of tasks that maintain homeostasis and overall health.
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...
1.8K